W. HOEKSTRA - Concepedia

Author

W. HOEKSTRA

Also Known As

Hoekstra, W.J., W. HOEKSTRA, W. J. HOEKSTRA, W. J. Hoekstra, W.J. Hoekstra, William Hoekstra

Publications

404

Citations

H-Index

Concepts

All Affiliations

W. HOEKSTRA is an author at Viamet Pharmaceuticals (United States) specializing in microbiology, clinical microbiology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	91
2	Microbiology	2	2	91
3	Health Sciences	1	1	80
4	Molecular Biology	1	1	11
5	Molecular Genetics	1	1	11

W. HOEKSTRA

Publications

382

Citations

H-Index

Page 1

	Year	Citations
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme Andrew G. S. Warrilow, Claire M. Hull, Josie E. Parker, Antimicrobial Agents and Chemotherapy	2014	162
Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis Edward P. Garvey, W. HOEKSTRA, Robert J. Schotzinger, Antimicrobial Agents and Chemotherapy Fungal Cell BiologyVaginal CandidiasisClinical MycologyAntimicrobial ChemotherapyRecurrent Vvc	2015	80
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds Wiley A. Schell, Alexander M. Jones, Edward P. Garvey, Antimicrobial Agents and Chemotherapy	2016	72
VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model Edward P. Garvey, W. HOEKSTRA, William R. Moore, Antimicrobial Agents and Chemotherapy	2015	57
The IncI Plasmids R144, R64 and ColIb Belong to One Exclusion Group R. A. Hartskeerl, E.M. Zuidweg, M. VAN GEFFEN, Microbiology GeneticsBacteriologyMolecular BiologyMolecular GeneticsColib Belong	1985	11

Page 1